CA2952500A1

CA2952500A1 - Compositions de therapie de retablissement de microbiote (mrt) et procedes de fabrication

Compositions de therapie de retablissement de microbiote (mrt) et procedes de fabrication Download PDF

Info

Publication number: CA2952500A1
Authority: CA; Canada
Prior art keywords: restoration therapy; microbiota restoration; therapy composition; administering; patient
Prior art date: 2015-12-30
Legal status : Pending

Application number

CA2952500A

Other languages

English (en)

Inventor

Joshua ERICKSON

Lee A. Jones

Courtney R. JONES

Beth Anne-Szkudlarek Brown

Current Assignee

Rebiotix Inc

Original Assignee

Rebiotix Inc

Priority date

2015-12-30

Filing date

2016-12-22

Publication date

2017-06-30

2015-12-30 Priority claimed from US14/984,413 external-priority patent/US9694039B2/en

2016-12-22 Application filed by Rebiotix Inc filed Critical Rebiotix Inc

2017-06-30 Publication of CA2952500A1 publication Critical patent/CA2952500A1/fr

Status Pending legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims abstract description 302
241000736262 Microbiota Species 0.000 title claims abstract description 147
238000000034 method Methods 0.000 title claims abstract description 140
238000002560 therapeutic procedure Methods 0.000 title claims abstract description 129
238000004519 manufacturing process Methods 0.000 title claims abstract description 42
239000000523 sample Substances 0.000 claims abstract description 178
241000282414 Homo sapiens Species 0.000 claims abstract description 105
230000002550 fecal effect Effects 0.000 claims abstract description 90
239000000706 filtrate Substances 0.000 claims abstract description 27
239000012470 diluted sample Substances 0.000 claims abstract description 15
238000002156 mixing Methods 0.000 claims abstract description 15
238000001914 filtration Methods 0.000 claims abstract description 14
238000007789 sealing Methods 0.000 claims abstract description 9
230000001580 bacterial effect Effects 0.000 claims description 76
241000894006 Bacteria Species 0.000 claims description 66
208000007386 hepatic encephalopathy Diseases 0.000 claims description 63
238000011282 treatment Methods 0.000 claims description 57
229920001223 polyethylene glycol Polymers 0.000 claims description 55
239000002202 Polyethylene glycol Substances 0.000 claims description 54
239000003814 drug Substances 0.000 claims description 48
230000003115 biocidal effect Effects 0.000 claims description 44
229940079593 drug Drugs 0.000 claims description 42
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 33
238000002203 pretreatment Methods 0.000 claims description 26
239000011780 sodium chloride Substances 0.000 claims description 23
208000019206 urinary tract infection Diseases 0.000 claims description 20
241000792859 Enema Species 0.000 claims description 19
239000007920 enema Substances 0.000 claims description 19
229940095399 enema Drugs 0.000 claims description 18
241001112695 Clostridiales Species 0.000 claims description 14
241000606126 Bacteroidaceae Species 0.000 claims description 11
241000692822 Bacteroidales Species 0.000 claims description 9
108010059993 Vancomycin Proteins 0.000 claims description 9
229960003040 rifaximin Drugs 0.000 claims description 9
NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 claims description 9
229960003165 vancomycin Drugs 0.000 claims description 9
MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 claims description 9
108010013198 Daptomycin Proteins 0.000 claims description 5
ZVGNESXIJDCBKN-WUIGKKEISA-N R-Tiacumicin B Natural products O([C@@H]1[C@@H](C)O[C@H]([C@H]([C@H]1O)OC)OCC1=CC=CC[C@H](O)C(C)=C[C@@H]([C@H](C(C)=CC(C)=CC[C@H](OC1=O)[C@@H](C)O)O[C@H]1[C@H]([C@@H](O)[C@H](OC(=O)C(C)C)C(C)(C)O1)O)CC)C(=O)C1=C(O)C(Cl)=C(O)C(Cl)=C1CC ZVGNESXIJDCBKN-WUIGKKEISA-N 0.000 claims description 5
108010053950 Teicoplanin Proteins 0.000 claims description 5
PPKJUHVNTMYXOD-PZGPJMECSA-N c49ws9n75l Chemical compound O=C([C@@H]1N(C2=O)CC[C@H]1S(=O)(=O)CCN(CC)CC)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(\C)=C\[C@@H](O)CC(=O)CC1=NC2=CO1.N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2C[C@@H](CS[C@H]3C4CCN(CC4)C3)C(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O PPKJUHVNTMYXOD-PZGPJMECSA-N 0.000 claims description 5
229940036735 ceftaroline Drugs 0.000 claims description 5
ZCCUWMICIWSJIX-NQJJCJBVSA-N ceftaroline fosamil Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OCC)C=2N=C(NP(O)(O)=O)SN=2)CC=1SC(SC=1)=NC=1C1=CC=[N+](C)C=C1 ZCCUWMICIWSJIX-NQJJCJBVSA-N 0.000 claims description 5
VOAZJEPQLGBXGO-SDAWRPRTSA-N ceftobiprole Chemical compound S1C(N)=NC(C(=N\O)\C(=O)N[C@@H]2C(N3C(=C(\C=C/4C(N([C@H]5CNCC5)CC\4)=O)CS[C@@H]32)C(O)=O)=O)=N1 VOAZJEPQLGBXGO-SDAWRPRTSA-N 0.000 claims description 5
229950004259 ceftobiprole Drugs 0.000 claims description 5
DDTDNCYHLGRFBM-YZEKDTGTSA-N chembl2367892 Chemical compound CC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@@H]([C@H]1C(N[C@@H](C2=CC(O)=CC(O[C@@H]3[C@H]([C@H](O)[C@H](O)[C@@H](CO)O3)O)=C2C=2C(O)=CC=C(C=2)[C@@H](NC(=O)[C@@H]2NC(=O)[C@@H]3C=4C=C(O)C=C(C=4)OC=4C(O)=CC=C(C=4)[C@@H](N)C(=O)N[C@H](CC=4C=C(Cl)C(O5)=CC=4)C(=O)N3)C(=O)N1)C(O)=O)=O)C(C=C1Cl)=CC=C1OC1=C(O[C@H]3[C@H]([C@@H](O)[C@H](O)[C@H](CO)O3)NC(C)=O)C5=CC2=C1 DDTDNCYHLGRFBM-YZEKDTGTSA-N 0.000 claims description 5
229960002488 dalbavancin Drugs 0.000 claims description 5
108700009376 dalbavancin Proteins 0.000 claims description 5
DOAKLVKFURWEDJ-QCMAZARJSA-N daptomycin Chemical compound C([C@H]1C(=O)O[C@H](C)[C@@H](C(NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](C(=O)N1)[C@H](C)CC(O)=O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CCCCCCCCC)C(=O)C1=CC=CC=C1N DOAKLVKFURWEDJ-QCMAZARJSA-N 0.000 claims description 5
229960005484 daptomycin Drugs 0.000 claims description 5
229960000628 fidaxomicin Drugs 0.000 claims description 5
ZVGNESXIJDCBKN-UUEYKCAUSA-N fidaxomicin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@H]([C@H]1O)OC)OCC\1=C/C=C/C[C@H](O)/C(C)=C/[C@@H]([C@H](/C(C)=C/C(/C)=C/C[C@H](OC/1=O)[C@@H](C)O)O[C@H]1[C@H]([C@@H](O)[C@H](OC(=O)C(C)C)C(C)(C)O1)O)CC)C(=O)C1=C(O)C(Cl)=C(O)C(Cl)=C1CC ZVGNESXIJDCBKN-UUEYKCAUSA-N 0.000 claims description 5
TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 claims description 5
229960003907 linezolid Drugs 0.000 claims description 5
VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims description 5
229960000282 metronidazole Drugs 0.000 claims description 5
108010071077 quinupristin-dalfopristin Proteins 0.000 claims description 5
229960001608 teicoplanin Drugs 0.000 claims description 5
ONUMZHGUFYIKPM-MXNFEBESSA-N telavancin Chemical compound O1[C@@H](C)[C@@H](O)[C@](NCCNCCCCCCCCCC)(C)C[C@@H]1O[C@H]1[C@H](OC=2C3=CC=4[C@H](C(N[C@H]5C(=O)N[C@H](C(N[C@@H](C6=CC(O)=C(CNCP(O)(O)=O)C(O)=C6C=6C(O)=CC=C5C=6)C(O)=O)=O)[C@H](O)C5=CC=C(C(=C5)Cl)O3)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC)[C@H](O)C3=CC=C(C(=C3)Cl)OC=2C=4)O[C@H](CO)[C@@H](O)[C@@H]1O ONUMZHGUFYIKPM-MXNFEBESSA-N 0.000 claims description 5
FPZLLRFZJZRHSY-HJYUBDRYSA-N tigecycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O FPZLLRFZJZRHSY-HJYUBDRYSA-N 0.000 claims description 5
229960004089 tigecycline Drugs 0.000 claims description 5
KGPGQDLTDHGEGT-JCIKCJKQSA-N zeven Chemical compound C=1C([C@@H]2C(=O)N[C@H](C(N[C@H](C3=CC(O)=C4)C(=O)NCCCN(C)C)=O)[C@H](O)C5=CC=C(C(=C5)Cl)OC=5C=C6C=C(C=5O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@H](O5)C(O)=O)NC(=O)CCCCCCCCC(C)C)OC5=CC=C(C=C5)C[C@@H]5C(=O)N[C@H](C(N[C@H]6C(=O)N2)=O)C=2C(Cl)=C(O)C=C(C=2)OC=2C(O)=CC=C(C=2)[C@H](C(N5)=O)NC)=CC=C(O)C=1C3=C4O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O KGPGQDLTDHGEGT-JCIKCJKQSA-N 0.000 claims description 5
MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 claims 2
239000002577 cryoprotective agent Substances 0.000 abstract description 53
238000012545 processing Methods 0.000 abstract description 38
239000003085 diluting agent Substances 0.000 abstract description 22
239000000047 product Substances 0.000 description 113
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 97
238000012360 testing method Methods 0.000 description 60
239000002775 capsule Substances 0.000 description 49
239000000463 material Substances 0.000 description 48
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 43
235000011187 glycerol Nutrition 0.000 description 33
230000035899 viability Effects 0.000 description 31
210000001035 gastrointestinal tract Anatomy 0.000 description 30
238000009472 formulation Methods 0.000 description 29
230000008569 process Effects 0.000 description 28
201000010099 disease Diseases 0.000 description 27
238000012216 screening Methods 0.000 description 27
239000000725 suspension Substances 0.000 description 26
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 24
238000003860 storage Methods 0.000 description 24
208000002551 irritable bowel syndrome Diseases 0.000 description 23
241000425347 Phyla <beetle> Species 0.000 description 22
239000000546 pharmaceutical excipient Substances 0.000 description 22
244000005709 gut microbiome Species 0.000 description 19
230000000813 microbial effect Effects 0.000 description 19
238000004806 packaging method and process Methods 0.000 description 18
230000000694 effects Effects 0.000 description 17
239000003826 tablet Substances 0.000 description 17
208000015181 infectious disease Diseases 0.000 description 16
150000001875 compounds Chemical class 0.000 description 15
230000000670 limiting effect Effects 0.000 description 15
-1 antifungals Substances 0.000 description 14
230000001684 chronic effect Effects 0.000 description 14
208000019425 cirrhosis of liver Diseases 0.000 description 14
208000035475 disorder Diseases 0.000 description 14
239000007788 liquid Substances 0.000 description 14
239000002245 particle Substances 0.000 description 14
230000036541 health Effects 0.000 description 13
241000894007 species Species 0.000 description 13
206010009657 Clostridium difficile colitis Diseases 0.000 description 12
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
229910021529 ammonia Inorganic materials 0.000 description 12
239000003242 anti bacterial agent Substances 0.000 description 12
208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 12
230000001225 therapeutic effect Effects 0.000 description 12
206010016654 Fibrosis Diseases 0.000 description 11
241001112693 Lachnospiraceae Species 0.000 description 11
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 11
229930006000 Sucrose Natural products 0.000 description 11
239000004480 active ingredient Substances 0.000 description 11
210000004369 blood Anatomy 0.000 description 11
239000008280 blood Substances 0.000 description 11
230000007882 cirrhosis Effects 0.000 description 11
239000005038 ethylene vinyl acetate Substances 0.000 description 11
235000013305 food Nutrition 0.000 description 11
244000005700 microbiome Species 0.000 description 11
239000008188 pellet Substances 0.000 description 11
239000005720 sucrose Substances 0.000 description 11
206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 10
206010009900 Colitis ulcerative Diseases 0.000 description 10
201000006704 Ulcerative Colitis Diseases 0.000 description 10
229940126534 drug product Drugs 0.000 description 10
239000000825 pharmaceutical preparation Substances 0.000 description 10
238000002360 preparation method Methods 0.000 description 10
210000002966 serum Anatomy 0.000 description 10
239000000243 solution Substances 0.000 description 10
241001430149 Clostridiaceae Species 0.000 description 9
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
241001112690 Eubacteriaceae Species 0.000 description 9
229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 9
241000692845 Rikenellaceae Species 0.000 description 9
241000095588 Ruminococcaceae Species 0.000 description 9
241000194018 Streptococcaceae Species 0.000 description 9
DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 9
210000001072 colon Anatomy 0.000 description 9
238000010790 dilution Methods 0.000 description 9
239000012895 dilution Substances 0.000 description 9
238000004108 freeze drying Methods 0.000 description 9
239000006187 pill Substances 0.000 description 9
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 9
208000011580 syndromic disease Diseases 0.000 description 9
208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 8
241001600148 Burkholderiales Species 0.000 description 8
208000037384 Clostridium Infections Diseases 0.000 description 8
206010054236 Clostridium difficile infection Diseases 0.000 description 8
208000011231 Crohn disease Diseases 0.000 description 8
208000018522 Gastrointestinal disease Diseases 0.000 description 8
241001465754 Metazoa Species 0.000 description 8
241000692843 Porphyromonadaceae Species 0.000 description 8
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
241000700605 Viruses Species 0.000 description 8
229940088710 antibiotic agent Drugs 0.000 description 8
208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 8
239000000969 carrier Substances 0.000 description 8
210000004027 cell Anatomy 0.000 description 8
238000001816 cooling Methods 0.000 description 8
238000007710 freezing Methods 0.000 description 8
230000008014 freezing Effects 0.000 description 8
239000004615 ingredient Substances 0.000 description 8
208000019423 liver disease Diseases 0.000 description 8
239000011148 porous material Substances 0.000 description 8
239000000843 powder Substances 0.000 description 8
238000003908 quality control method Methods 0.000 description 8
238000013207 serial dilution Methods 0.000 description 8
230000004083 survival effect Effects 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
108020004465 16S ribosomal RNA Proteins 0.000 description 7
206010010774 Constipation Diseases 0.000 description 7
108010010803 Gelatin Proteins 0.000 description 7
238000004458 analytical method Methods 0.000 description 7
239000011230 binding agent Substances 0.000 description 7
238000012258 culturing Methods 0.000 description 7
239000008273 gelatin Substances 0.000 description 7
229920000159 gelatin Polymers 0.000 description 7
235000019322 gelatine Nutrition 0.000 description 7
235000011852 gelatine desserts Nutrition 0.000 description 7
238000007689 inspection Methods 0.000 description 7
210000000936 intestine Anatomy 0.000 description 7
230000007774 longterm Effects 0.000 description 7
239000006041 probiotic Substances 0.000 description 7
235000018291 probiotics Nutrition 0.000 description 7
239000007787 solid Substances 0.000 description 7
210000002784 stomach Anatomy 0.000 description 7
238000010257 thawing Methods 0.000 description 7
MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 description 7
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 6
241000606125 Bacteroides Species 0.000 description 6
241000193163 Clostridioides difficile Species 0.000 description 6
208000015943 Coeliac disease Diseases 0.000 description 6
241000233866 Fungi Species 0.000 description 6
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
206010020575 Hyperammonaemia Diseases 0.000 description 6
206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 6
208000008589 Obesity Diseases 0.000 description 6
208000018737 Parkinson disease Diseases 0.000 description 6
206010057244 Post viral fatigue syndrome Diseases 0.000 description 6
208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 6
230000001154 acute effect Effects 0.000 description 6
206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 6
239000000427 antigen Substances 0.000 description 6
108091007433 antigens Proteins 0.000 description 6
102000036639 antigens Human genes 0.000 description 6
201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 6
239000000499 gel Substances 0.000 description 6
KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 6
230000000968 intestinal effect Effects 0.000 description 6
239000000314 lubricant Substances 0.000 description 6
201000006417 multiple sclerosis Diseases 0.000 description 6
235000020824 obesity Nutrition 0.000 description 6
229920000642 polymer Polymers 0.000 description 6
230000000306 recurrent effect Effects 0.000 description 6
206010039073 rheumatoid arthritis Diseases 0.000 description 6
235000020183 skimmed milk Nutrition 0.000 description 6
229920001817 Agar Polymers 0.000 description 5
KWTQSFXGGICVPE-WCCKRBBISA-N Arginine hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCCN=C(N)N KWTQSFXGGICVPE-WCCKRBBISA-N 0.000 description 5
208000024172 Cardiovascular disease Diseases 0.000 description 5
206010009944 Colon cancer Diseases 0.000 description 5
206010020751 Hypersensitivity Diseases 0.000 description 5
229920002472 Starch Polymers 0.000 description 5
239000008272 agar Substances 0.000 description 5
238000013019 agitation Methods 0.000 description 5
230000008901 benefit Effects 0.000 description 5
239000012620 biological material Substances 0.000 description 5
238000005119 centrifugation Methods 0.000 description 5
238000012512 characterization method Methods 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
206010009887 colitis Diseases 0.000 description 5
230000002526 effect on cardiovascular system Effects 0.000 description 5
238000005538 encapsulation Methods 0.000 description 5
244000005702 human microbiome Species 0.000 description 5
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 5
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 5
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 5
239000008107 starch Substances 0.000 description 5
235000019698 starch Nutrition 0.000 description 5
239000000829 suppository Substances 0.000 description 5
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
241000416162 Astragalus gummifer Species 0.000 description 4
206010003805 Autism Diseases 0.000 description 4
208000020706 Autistic disease Diseases 0.000 description 4
208000023275 Autoimmune disease Diseases 0.000 description 4
206010012735 Diarrhoea Diseases 0.000 description 4
241000196324 Embryophyta Species 0.000 description 4
208000001640 Fibromyalgia Diseases 0.000 description 4
206010017993 Gastrointestinal neoplasms Diseases 0.000 description 4
241000224466 Giardia Species 0.000 description 4
241000282412 Homo Species 0.000 description 4
208000022559 Inflammatory bowel disease Diseases 0.000 description 4
208000003456 Juvenile Arthritis Diseases 0.000 description 4
206010059176 Juvenile idiopathic arthritis Diseases 0.000 description 4
241000124008 Mammalia Species 0.000 description 4
RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 4
206010068871 Myotonic dystrophy Diseases 0.000 description 4
206010039710 Scleroderma Diseases 0.000 description 4
241000191967 Staphylococcus aureus Species 0.000 description 4
229920001615 Tragacanth Polymers 0.000 description 4
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 4
108010046334 Urease Proteins 0.000 description 4
239000008186 active pharmaceutical agent Substances 0.000 description 4
235000010443 alginic acid Nutrition 0.000 description 4
229920000615 alginic acid Polymers 0.000 description 4
239000001986 bile esculin agar Substances 0.000 description 4
238000009534 blood test Methods 0.000 description 4
239000004202 carbamide Substances 0.000 description 4
235000010980 cellulose Nutrition 0.000 description 4
229920002678 cellulose Polymers 0.000 description 4
239000001913 cellulose Substances 0.000 description 4
230000001332 colony forming effect Effects 0.000 description 4
230000003412 degenerative effect Effects 0.000 description 4
230000029087 digestion Effects 0.000 description 4
230000001079 digestive effect Effects 0.000 description 4
208000010643 digestive system disease Diseases 0.000 description 4
229940088679 drug related substance Drugs 0.000 description 4
201000006549 dyspepsia Diseases 0.000 description 4
210000003608 fece Anatomy 0.000 description 4
239000006260 foam Substances 0.000 description 4
208000018685 gastrointestinal system disease Diseases 0.000 description 4
208000002672 hepatitis B Diseases 0.000 description 4
208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 4
201000006747 infectious mononucleosis Diseases 0.000 description 4
201000002215 juvenile rheumatoid arthritis Diseases 0.000 description 4
239000007937 lozenge Substances 0.000 description 4
206010025135 lupus erythematosus Diseases 0.000 description 4
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
229960003085 meticillin Drugs 0.000 description 4
239000013588 oral product Substances 0.000 description 4
229940023486 oral product Drugs 0.000 description 4
238000012856 packing Methods 0.000 description 4
244000045947 parasite Species 0.000 description 4
244000052769 pathogen Species 0.000 description 4
229940068196 placebo Drugs 0.000 description 4
239000000902 placebo Substances 0.000 description 4
210000001236 prokaryotic cell Anatomy 0.000 description 4
235000018102 proteins Nutrition 0.000 description 4
108090000623 proteins and genes Proteins 0.000 description 4
102000004169 proteins and genes Human genes 0.000 description 4
230000001373 regressive effect Effects 0.000 description 4
230000004044 response Effects 0.000 description 4
238000010561 standard procedure Methods 0.000 description 4
238000002563 stool test Methods 0.000 description 4
238000002054 transplantation Methods 0.000 description 4
DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 3
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
208000035473 Communicable disease Diseases 0.000 description 3
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
208000020401 Depressive disease Diseases 0.000 description 3
241000588921 Enterobacteriaceae Species 0.000 description 3
241000588724 Escherichia coli Species 0.000 description 3
241000192125 Firmicutes Species 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
239000004471 Glycine Substances 0.000 description 3
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
241000567229 Isospora Species 0.000 description 3
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
229930195725 Mannitol Natural products 0.000 description 3
241001263478 Norovirus Species 0.000 description 3
229940123973 Oxygen scavenger Drugs 0.000 description 3
241001494479 Pecora Species 0.000 description 3
208000018262 Peripheral vascular disease Diseases 0.000 description 3
239000004372 Polyvinyl alcohol Substances 0.000 description 3
241000692844 Prevotellaceae Species 0.000 description 3
208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 3
241000607142 Salmonella Species 0.000 description 3
208000034972 Sudden Infant Death Diseases 0.000 description 3
206010042440 Sudden infant death syndrome Diseases 0.000 description 3
239000000654 additive Substances 0.000 description 3
230000002411 adverse Effects 0.000 description 3
239000000783 alginic acid Substances 0.000 description 3
229960001126 alginic acid Drugs 0.000 description 3
150000004781 alginic acids Chemical class 0.000 description 3
208000030961 allergic reaction Diseases 0.000 description 3
230000003466 anti-cipated effect Effects 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
229960003237 betaine Drugs 0.000 description 3
239000006161 blood agar Substances 0.000 description 3
230000037396 body weight Effects 0.000 description 3
235000014633 carbohydrates Nutrition 0.000 description 3
208000029742 colonic neoplasm Diseases 0.000 description 3
238000002052 colonoscopy Methods 0.000 description 3
239000000470 constituent Substances 0.000 description 3
239000006071 cream Substances 0.000 description 3
239000008121 dextrose Substances 0.000 description 3
239000002552 dosage form Substances 0.000 description 3
239000003937 drug carrier Substances 0.000 description 3
244000000021 enteric pathogen Species 0.000 description 3
239000000796 flavoring agent Substances 0.000 description 3
235000013355 food flavoring agent Nutrition 0.000 description 3
230000002496 gastric effect Effects 0.000 description 3
239000008187 granular material Substances 0.000 description 3
230000003862 health status Effects 0.000 description 3
238000000265 homogenisation Methods 0.000 description 3
239000001863 hydroxypropyl cellulose Substances 0.000 description 3
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 3
230000006872 improvement Effects 0.000 description 3
239000003701 inert diluent Substances 0.000 description 3
238000002372 labelling Methods 0.000 description 3
239000008101 lactose Substances 0.000 description 3
JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 3
229960000511 lactulose Drugs 0.000 description 3
PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 3
230000014759 maintenance of location Effects 0.000 description 3
239000000594 mannitol Substances 0.000 description 3
235000010355 mannitol Nutrition 0.000 description 3
238000005259 measurement Methods 0.000 description 3
230000002503 metabolic effect Effects 0.000 description 3
206010027599 migraine Diseases 0.000 description 3
235000013336 milk Nutrition 0.000 description 3
239000008267 milk Substances 0.000 description 3
210000004080 milk Anatomy 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
238000007747 plating Methods 0.000 description 3
229920001992 poloxamer 407 Polymers 0.000 description 3
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
229920000053 polysorbate 80 Polymers 0.000 description 3
229920000166 polytrimethylene carbonate Polymers 0.000 description 3
229920002451 polyvinyl alcohol Polymers 0.000 description 3
230000000529 probiotic effect Effects 0.000 description 3
238000005057 refrigeration Methods 0.000 description 3
238000012552 review Methods 0.000 description 3
150000004666 short chain fatty acids Chemical class 0.000 description 3
235000021391 short chain fatty acids Nutrition 0.000 description 3
241000701161 unidentified adenovirus Species 0.000 description 3
238000010792 warming Methods 0.000 description 3
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
108091064702 1 family Proteins 0.000 description 2
208000030507 AIDS Diseases 0.000 description 2
208000002874 Acne Vulgaris Diseases 0.000 description 2
241000607534 Aeromonas Species 0.000 description 2
241000589013 Alcaligenaceae Species 0.000 description 2
208000024827 Alzheimer disease Diseases 0.000 description 2
244000144730 Amygdalus persica Species 0.000 description 2
206010061424 Anal cancer Diseases 0.000 description 2
206010002556 Ankylosing Spondylitis Diseases 0.000 description 2
208000000103 Anorexia Nervosa Diseases 0.000 description 2
208000007860 Anus Neoplasms Diseases 0.000 description 2
241000203069 Archaea Species 0.000 description 2
208000037157 Azotemia Diseases 0.000 description 2
206010070545 Bacterial translocation Diseases 0.000 description 2
241000605059 Bacteroidetes Species 0.000 description 2
208000027496 Behcet disease Diseases 0.000 description 2
208000009137 Behcet syndrome Diseases 0.000 description 2
208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 2
208000033222 Biliary cirrhosis primary Diseases 0.000 description 2
206010008609 Cholangitis sclerosing Diseases 0.000 description 2
208000017667 Chronic Disease Diseases 0.000 description 2
208000000668 Chronic Pancreatitis Diseases 0.000 description 2
208000030939 Chronic inflammatory demyelinating polyneuropathy Diseases 0.000 description 2
208000035984 Colonic Polyps Diseases 0.000 description 2
208000001333 Colorectal Neoplasms Diseases 0.000 description 2
206010010904 Convulsion Diseases 0.000 description 2
229920002261 Corn starch Polymers 0.000 description 2
208000014997 Crohn colitis Diseases 0.000 description 2
206010063075 Cryptogenic cirrhosis Diseases 0.000 description 2
241000223935 Cryptosporidium Species 0.000 description 2
244000000626 Daucus carota Species 0.000 description 2
235000002767 Daucus carota Nutrition 0.000 description 2
206010012468 Dermatitis herpetiformis Diseases 0.000 description 2
208000012258 Diverticular disease Diseases 0.000 description 2
206010013554 Diverticulum Diseases 0.000 description 2
208000014094 Dystonic disease Diseases 0.000 description 2
241000588914 Enterobacter Species 0.000 description 2
241000305071 Enterobacterales Species 0.000 description 2
208000000461 Esophageal Neoplasms Diseases 0.000 description 2
206010016207 Familial Mediterranean fever Diseases 0.000 description 2
208000004930 Fatty Liver Diseases 0.000 description 2
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
208000022072 Gallbladder Neoplasms Diseases 0.000 description 2
208000005577 Gastroenteritis Diseases 0.000 description 2
206010068189 Gastroenteritis norovirus Diseases 0.000 description 2
206010017913 Gastroenteritis rotavirus Diseases 0.000 description 2
206010017918 Gastroenteritis viral Diseases 0.000 description 2
206010051066 Gastrointestinal stromal tumour Diseases 0.000 description 2
206010018429 Glucose tolerance impaired Diseases 0.000 description 2
208000034308 Grand mal convulsion Diseases 0.000 description 2
206010069691 HIV enteropathy Diseases 0.000 description 2
208000032759 Hemolytic-Uremic Syndrome Diseases 0.000 description 2
206010019708 Hepatic steatosis Diseases 0.000 description 2
208000005176 Hepatitis C Diseases 0.000 description 2
208000013016 Hypoglycemia Diseases 0.000 description 2
201000005081 Intestinal Pseudo-Obstruction Diseases 0.000 description 2
241000588747 Klebsiella pneumoniae Species 0.000 description 2
241001112724 Lactobacillales Species 0.000 description 2
235000010643 Leucaena leucocephala Nutrition 0.000 description 2
240000007472 Leucaena leucocephala Species 0.000 description 2
208000016604 Lyme disease Diseases 0.000 description 2
244000246386 Mentha pulegium Species 0.000 description 2
235000016257 Mentha pulegium Nutrition 0.000 description 2
235000004357 Mentha x piperita Nutrition 0.000 description 2
229920000168 Microcrystalline cellulose Polymers 0.000 description 2
208000019695 Migraine disease Diseases 0.000 description 2
208000002033 Myoclonus Diseases 0.000 description 2
229930193140 Neomycin Natural products 0.000 description 2
208000012902 Nervous system disease Diseases 0.000 description 2
208000025966 Neurological disease Diseases 0.000 description 2
206010030155 Oesophageal carcinoma Diseases 0.000 description 2
208000012868 Overgrowth Diseases 0.000 description 2
208000002193 Pain Diseases 0.000 description 2
208000035467 Pancreatic insufficiency Diseases 0.000 description 2
206010061902 Pancreatic neoplasm Diseases 0.000 description 2
206010033649 Pancreatitis chronic Diseases 0.000 description 2
206010034759 Petit mal epilepsy Diseases 0.000 description 2
241000607000 Plesiomonas Species 0.000 description 2
208000012654 Primary biliary cholangitis Diseases 0.000 description 2
208000035955 Proximal myotonic myopathy Diseases 0.000 description 2
235000006040 Prunus persica var persica Nutrition 0.000 description 2
208000028017 Psychotic disease Diseases 0.000 description 2
208000033464 Reiter syndrome Diseases 0.000 description 2
208000006289 Rett Syndrome Diseases 0.000 description 2
208000025747 Rheumatic disease Diseases 0.000 description 2
108010017898 Shiga Toxins Proteins 0.000 description 2
241000607768 Shigella Species 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
208000021386 Sjogren Syndrome Diseases 0.000 description 2
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
206010071061 Small intestinal bacterial overgrowth Diseases 0.000 description 2
208000007156 Spondylarthritis Diseases 0.000 description 2
201000002661 Spondylitis Diseases 0.000 description 2
241000295644 Staphylococcaceae Species 0.000 description 2
208000005718 Stomach Neoplasms Diseases 0.000 description 2
241000813827 Sutterellaceae Species 0.000 description 2
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
208000025865 Ulcer Diseases 0.000 description 2
208000024780 Urticaria Diseases 0.000 description 2
206010052568 Urticaria chronic Diseases 0.000 description 2
206010047115 Vasculitis Diseases 0.000 description 2
241000607734 Yersinia <bacteria> Species 0.000 description 2
230000003187 abdominal effect Effects 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
206010000496 acne Diseases 0.000 description 2
230000009471 action Effects 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
230000007815 allergy Effects 0.000 description 2
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
206010002022 amyloidosis Diseases 0.000 description 2
208000022531 anorexia Diseases 0.000 description 2
201000011165 anus cancer Diseases 0.000 description 2
206010003246 arthritis Diseases 0.000 description 2
235000010323 ascorbic acid Nutrition 0.000 description 2
229960005070 ascorbic acid Drugs 0.000 description 2
239000011668 ascorbic acid Substances 0.000 description 2
230000007375 bacterial translocation Effects 0.000 description 2
210000000941 bile Anatomy 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
230000008859 change Effects 0.000 description 2
239000003610 charcoal Substances 0.000 description 2
235000013351 cheese Nutrition 0.000 description 2
201000005795 chronic inflammatory demyelinating polyneuritis Diseases 0.000 description 2
208000024376 chronic urticaria Diseases 0.000 description 2
229940110456 cocoa butter Drugs 0.000 description 2
235000019868 cocoa butter Nutrition 0.000 description 2
208000008609 collagenous colitis Diseases 0.000 description 2
229940075614 colloidal silicon dioxide Drugs 0.000 description 2
230000000112 colonic effect Effects 0.000 description 2
239000008120 corn starch Substances 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
201000003278 cryoglobulinemia Diseases 0.000 description 2
238000005138 cryopreservation Methods 0.000 description 2
230000002338 cryopreservative effect Effects 0.000 description 2
230000001186 cumulative effect Effects 0.000 description 2
206010061428 decreased appetite Diseases 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
238000002716 delivery method Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 2
231100000673 dose–response relationship Toxicity 0.000 description 2
208000010118 dystonia Diseases 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
239000002158 endotoxin Substances 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
239000002702 enteric coating Substances 0.000 description 2
238000009505 enteric coating Methods 0.000 description 2
201000004101 esophageal cancer Diseases 0.000 description 2
210000003527 eukaryotic cell Anatomy 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
239000000284 extract Substances 0.000 description 2
208000003816 familial cirrhosis Diseases 0.000 description 2
208000010706 fatty liver disease Diseases 0.000 description 2
239000000835 fiber Substances 0.000 description 2
239000000945 filler Substances 0.000 description 2
238000011049 filling Methods 0.000 description 2
239000012530 fluid Substances 0.000 description 2
235000003599 food sweetener Nutrition 0.000 description 2
230000006870 function Effects 0.000 description 2
201000010175 gallbladder cancer Diseases 0.000 description 2
206010017758 gastric cancer Diseases 0.000 description 2
208000021302 gastroesophageal reflux disease Diseases 0.000 description 2
201000011243 gastrointestinal stromal tumor Diseases 0.000 description 2
239000007903 gelatin capsule Substances 0.000 description 2
239000003349 gelling agent Substances 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
230000012010 growth Effects 0.000 description 2
230000002949 hemolytic effect Effects 0.000 description 2
208000005252 hepatitis A Diseases 0.000 description 2
235000001050 hortel pimenta Nutrition 0.000 description 2
230000002218 hypoglycaemic effect Effects 0.000 description 2
229960003943 hypromellose Drugs 0.000 description 2
235000015243 ice cream Nutrition 0.000 description 2
238000011534 incubation Methods 0.000 description 2
208000027138 indeterminate colitis Diseases 0.000 description 2
230000000266 injurious effect Effects 0.000 description 2
206010022437 insomnia Diseases 0.000 description 2
230000003993 interaction Effects 0.000 description 2
239000011872 intimate mixture Substances 0.000 description 2
238000011835 investigation Methods 0.000 description 2
229920006008 lipopolysaccharide Polymers 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
201000007270 liver cancer Diseases 0.000 description 2
208000014018 liver neoplasm Diseases 0.000 description 2
235000019359 magnesium stearate Nutrition 0.000 description 2
208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
238000003361 measurement systems analysis Methods 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
239000012528 membrane Substances 0.000 description 2
238000005374 membrane filtration Methods 0.000 description 2
229960001047 methyl salicylate Drugs 0.000 description 2
229940016286 microcrystalline cellulose Drugs 0.000 description 2
235000019813 microcrystalline cellulose Nutrition 0.000 description 2
239000008108 microcrystalline cellulose Substances 0.000 description 2
244000005706 microflora Species 0.000 description 2
208000008275 microscopic colitis Diseases 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
206010028417 myasthenia gravis Diseases 0.000 description 2
201000008709 myotonic dystrophy type 2 Diseases 0.000 description 2
229960004927 neomycin Drugs 0.000 description 2
201000008383 nephritis Diseases 0.000 description 2
230000000926 neurological effect Effects 0.000 description 2
230000035764 nutrition Effects 0.000 description 2
235000016709 nutrition Nutrition 0.000 description 2
201000002528 pancreatic cancer Diseases 0.000 description 2
208000008443 pancreatic carcinoma Diseases 0.000 description 2
239000006072 paste Substances 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
239000008194 pharmaceutical composition Substances 0.000 description 2
208000015768 polyposis Diseases 0.000 description 2
235000013406 prebiotics Nutrition 0.000 description 2
201000000742 primary sclerosing cholangitis Diseases 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
238000012372 quality testing Methods 0.000 description 2
208000002574 reactive arthritis Diseases 0.000 description 2
238000011084 recovery Methods 0.000 description 2
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
229940081974 saccharin Drugs 0.000 description 2
235000019204 saccharin Nutrition 0.000 description 2
239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
238000005464 sample preparation method Methods 0.000 description 2
201000000980 schizophrenia Diseases 0.000 description 2
208000010157 sclerosing cholangitis Diseases 0.000 description 2
230000007142 small intestinal bacterial overgrowth Effects 0.000 description 2
239000007921 spray Substances 0.000 description 2
238000010186 staining Methods 0.000 description 2
231100000240 steatosis hepatitis Toxicity 0.000 description 2
201000011549 stomach cancer Diseases 0.000 description 2
239000000126 substance Substances 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
239000002511 suppository base Substances 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
239000003765 sweetening agent Substances 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
201000000596 systemic lupus erythematosus Diseases 0.000 description 2
239000000454 talc Substances 0.000 description 2
229910052623 talc Inorganic materials 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
235000010487 tragacanth Nutrition 0.000 description 2
239000000196 tragacanth Substances 0.000 description 2
229940116362 tragacanth Drugs 0.000 description 2
230000032258 transport Effects 0.000 description 2
208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
231100000397 ulcer Toxicity 0.000 description 2
230000002568 urticarial effect Effects 0.000 description 2
208000019553 vascular disease Diseases 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
235000013343 vitamin Nutrition 0.000 description 2
229940088594 vitamin Drugs 0.000 description 2
239000011782 vitamin Substances 0.000 description 2
229930003231 vitamin Natural products 0.000 description 2
235000001892 vitamin D2 Nutrition 0.000 description 2
239000002699 waste material Substances 0.000 description 2
239000001993 wax Substances 0.000 description 2
239000000080 wetting agent Substances 0.000 description 2
235000013618 yogurt Nutrition 0.000 description 2
BDEDPKFUFGCVCJ-UHFFFAOYSA-N 3,6-dihydroxy-8,8-dimethyl-1-oxo-3,4,7,9-tetrahydrocyclopenta[h]isochromene-5-carbaldehyde Chemical compound O=C1OC(O)CC(C(C=O)=C2O)=C1C1=C2CC(C)(C)C1 BDEDPKFUFGCVCJ-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
241000588626 Acinetobacter baumannii Species 0.000 description 1
241001156739 Actinobacteria <phylum> Species 0.000 description 1
241001135756 Alphaproteobacteria Species 0.000 description 1
241000224489 Amoeba Species 0.000 description 1
241000193833 Bacillales Species 0.000 description 1
241000304886 Bacilli Species 0.000 description 1
241001141113 Bacteroidia Species 0.000 description 1
229920002498 Beta-glucan Polymers 0.000 description 1
241001135755 Betaproteobacteria Species 0.000 description 1
241001430332 Bifidobacteriaceae Species 0.000 description 1
241001655328 Bifidobacteriales Species 0.000 description 1
241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 1
241001608472 Bifidobacterium longum Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
208000014644 Brain disease Diseases 0.000 description 1
241001453380 Burkholderia Species 0.000 description 1
241000253402 Burkholderiaceae Species 0.000 description 1
FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
241000222120 Candida <Saccharomycetales> Species 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
241000283707 Capra Species 0.000 description 1
241001352294 Catabacteriaceae Species 0.000 description 1
241000700198 Cavia Species 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
229920002101 Chitin Polymers 0.000 description 1
206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
241001112696 Clostridia Species 0.000 description 1
241000193403 Clostridium Species 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
241001657523 Coriobacteriaceae Species 0.000 description 1
241001662464 Coriobacteriales Species 0.000 description 1
241001662466 Coriobacteriia Species 0.000 description 1
241001503832 Cryptospora Species 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
208000032274 Encephalopathy Diseases 0.000 description 1
241000224432 Entamoeba histolytica Species 0.000 description 1
241000194033 Enterococcus Species 0.000 description 1
241001114405 Entomoplasmatales Species 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241000609971 Erysipelotrichaceae Species 0.000 description 1
241001081257 Erysipelotrichales Species 0.000 description 1
241001081259 Erysipelotrichia Species 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
238000012424 Freeze-thaw process Methods 0.000 description 1
241000192128 Gammaproteobacteria Species 0.000 description 1
208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
108010034145 Helminth Proteins Proteins 0.000 description 1
SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
241001272567 Hominoidea Species 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
229930064664 L-arginine Natural products 0.000 description 1
235000014852 L-arginine Nutrition 0.000 description 1
241001468155 Lactobacillaceae Species 0.000 description 1
244000199885 Lactobacillus bulgaricus Species 0.000 description 1
235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
239000004166 Lanolin Substances 0.000 description 1
241000186781 Listeria Species 0.000 description 1
206010026749 Mania Diseases 0.000 description 1
241000604449 Megasphaera Species 0.000 description 1
206010049567 Miller Fisher syndrome Diseases 0.000 description 1
241001430197 Mollicutes Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
241000187479 Mycobacterium tuberculosis Species 0.000 description 1
206010029155 Nephropathy toxic Diseases 0.000 description 1
206010033109 Ototoxicity Diseases 0.000 description 1
241001112734 Paenibacillaceae Species 0.000 description 1
241000282579 Pan Species 0.000 description 1
241001112694 Peptococcaceae Species 0.000 description 1
241001112692 Peptostreptococcaceae Species 0.000 description 1
241000223960 Plasmodium falciparum Species 0.000 description 1
241000223810 Plasmodium vivax Species 0.000 description 1
229920002732 Polyanhydride Polymers 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
229920001710 Polyorthoester Polymers 0.000 description 1
208000002389 Pouchitis Diseases 0.000 description 1
241000288906 Primates Species 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
241000192142 Proteobacteria Species 0.000 description 1
206010037128 Pseudomembranous colitis Diseases 0.000 description 1
241000589517 Pseudomonas aeruginosa Species 0.000 description 1
241000700159 Rattus Species 0.000 description 1
229920000294 Resistant starch Polymers 0.000 description 1
241000589157 Rhizobiales Species 0.000 description 1
241000253387 Rhodobiaceae Species 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
229920001800 Shellac Polymers 0.000 description 1
241000107801 Shewanellaceae Species 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
241000202919 Spiroplasmataceae Species 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
241000193998 Streptococcus pneumoniae Species 0.000 description 1
229920006328 Styrofoam Polymers 0.000 description 1
241000282887 Suidae Species 0.000 description 1
241000131694 Tenericutes Species 0.000 description 1
241000223997 Toxoplasma gondii Species 0.000 description 1
241000589886 Treponema Species 0.000 description 1
229920000690 Tyvek Polymers 0.000 description 1
241001430183 Veillonellaceae Species 0.000 description 1
241001183271 Verrucomicrobiaceae Species 0.000 description 1
241001183192 Verrucomicrobiae Species 0.000 description 1
241000230320 Verrucomicrobiales Species 0.000 description 1
241000607598 Vibrio Species 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
238000011360 adjunctive therapy Methods 0.000 description 1
208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
229930013930 alkaloid Natural products 0.000 description 1
230000004075 alteration Effects 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
230000003321 amplification Effects 0.000 description 1
239000003708 ampul Substances 0.000 description 1
238000012863 analytical testing Methods 0.000 description 1
238000010171 animal model Methods 0.000 description 1
235000021120 animal protein Nutrition 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
230000002141 anti-parasite Effects 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
229940125687 antiparasitic agent Drugs 0.000 description 1
239000003096 antiparasitic agent Substances 0.000 description 1
239000003443 antiviral agent Substances 0.000 description 1
229940121357 antivirals Drugs 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
235000012216 bentonite Nutrition 0.000 description 1
229940009289 bifidobacterium lactis Drugs 0.000 description 1
229940009291 bifidobacterium longum Drugs 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
238000010876 biochemical test Methods 0.000 description 1
229920000249 biocompatible polymer Polymers 0.000 description 1
229960000074 biopharmaceutical Drugs 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
208000028683 bipolar I disease Diseases 0.000 description 1
238000004159 blood analysis Methods 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
230000003139 buffering effect Effects 0.000 description 1
230000009172 bursting Effects 0.000 description 1
235000012241 calcium silicate Nutrition 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
239000007963 capsule composition Substances 0.000 description 1
108010068385 carbapenemase Proteins 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
235000021466 carotenoid Nutrition 0.000 description 1
150000001747 carotenoids Chemical class 0.000 description 1
229920001525 carrageenan Polymers 0.000 description 1
235000010418 carrageenan Nutrition 0.000 description 1
210000004534 cecum Anatomy 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
235000013339 cereals Nutrition 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
229940112822 chewing gum Drugs 0.000 description 1
235000015218 chewing gum Nutrition 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
230000019771 cognition Effects 0.000 description 1
208000010877 cognitive disease Diseases 0.000 description 1
230000001149 cognitive effect Effects 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
239000003086 colorant Substances 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
210000000795 conjunctiva Anatomy 0.000 description 1
239000013068 control sample Substances 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000012136 culture method Methods 0.000 description 1
230000007123 defense Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000000151 deposition Methods 0.000 description 1
239000002274 desiccant Substances 0.000 description 1
238000013461 design Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
235000013325 dietary fiber Nutrition 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
102000038379 digestive enzymes Human genes 0.000 description 1
108091007734 digestive enzymes Proteins 0.000 description 1
239000007884 disintegrant Substances 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000007140 dysbiosis Effects 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
235000013601 eggs Nutrition 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
238000001839 endoscopy Methods 0.000 description 1
229940079360 enema for constipation Drugs 0.000 description 1
230000037149 energy metabolism Effects 0.000 description 1
229940007078 entamoeba histolytica Drugs 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
BFMKFCLXZSUVPI-UHFFFAOYSA-N ethyl but-3-enoate Chemical compound CCOC(=O)CC=C BFMKFCLXZSUVPI-UHFFFAOYSA-N 0.000 description 1
230000029142 excretion Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000000887 face Anatomy 0.000 description 1
239000003925 fat Substances 0.000 description 1
235000019197 fats Nutrition 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
239000002657 fibrous material Substances 0.000 description 1
235000021323 fish oil Nutrition 0.000 description 1
235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
150000003271 galactooligosaccharides Chemical class 0.000 description 1
239000007789 gas Substances 0.000 description 1
210000005095 gastrointestinal system Anatomy 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
244000000013 helminth Species 0.000 description 1
230000010224 hepatic metabolism Effects 0.000 description 1
229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000001802 infusion Methods 0.000 description 1
238000011221 initial treatment Methods 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
229960000367 inositol Drugs 0.000 description 1
239000011810 insulating material Substances 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
230000002262 irrigation Effects 0.000 description 1
238000003973 irrigation Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
229940039717 lanolin Drugs 0.000 description 1
235000019388 lanolin Nutrition 0.000 description 1
210000002429 large intestine Anatomy 0.000 description 1
230000001418 larval effect Effects 0.000 description 1
230000002475 laxative effect Effects 0.000 description 1
229920005610 lignin Polymers 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
239000006194 liquid suspension Substances 0.000 description 1
230000003910 liver physiology Effects 0.000 description 1
235000011475 lollipops Nutrition 0.000 description 1
RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 1
229960001571 loperamide Drugs 0.000 description 1
239000006210 lotion Substances 0.000 description 1
238000012792 lyophilization process Methods 0.000 description 1
VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
239000000347 magnesium hydroxide Substances 0.000 description 1
229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
238000009115 maintenance therapy Methods 0.000 description 1
201000004792 malaria Diseases 0.000 description 1
238000007726 management method Methods 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
210000004379 membrane Anatomy 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
239000004530 micro-emulsion Substances 0.000 description 1
244000000010 microbial pathogen Species 0.000 description 1
239000003094 microcapsule Substances 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
238000012806 monitoring device Methods 0.000 description 1
238000000465 moulding Methods 0.000 description 1
210000002200 mouth mucosa Anatomy 0.000 description 1
230000004682 mucosal barrier function Effects 0.000 description 1
210000003097 mucus Anatomy 0.000 description 1
201000009671 multidrug-resistant tuberculosis Diseases 0.000 description 1
231100000417 nephrotoxicity Toxicity 0.000 description 1
230000007694 nephrotoxicity Effects 0.000 description 1
238000010855 neuropsychological testing Methods 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 1
235000021095 non-nutrients Nutrition 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
239000003921 oil Substances 0.000 description 1
239000002674 ointment Substances 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
150000002898 organic sulfur compounds Chemical class 0.000 description 1
231100000262 ototoxicity Toxicity 0.000 description 1
238000001139 pH measurement Methods 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
230000003071 parasitic effect Effects 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
235000010603 pastilles Nutrition 0.000 description 1
230000007310 pathophysiology Effects 0.000 description 1
239000001814 pectin Substances 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
235000010987 pectin Nutrition 0.000 description 1
239000002304 perfume Substances 0.000 description 1
235000019271 petrolatum Nutrition 0.000 description 1
230000003285 pharmacodynamic effect Effects 0.000 description 1
XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
230000035479 physiological effects, processes and functions Effects 0.000 description 1
235000017807 phytochemicals Nutrition 0.000 description 1
229930000223 plant secondary metabolite Natural products 0.000 description 1
230000036470 plasma concentration Effects 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004033 plastic Substances 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
229920000747 poly(lactic acid) Polymers 0.000 description 1
229920006267 polyester film Polymers 0.000 description 1
229940068917 polyethylene glycols Drugs 0.000 description 1
229920000139 polyethylene terephthalate Polymers 0.000 description 1
239000005020 polyethylene terephthalate Substances 0.000 description 1
239000004633 polyglycolic acid Substances 0.000 description 1
239000004626 polylactic acid Substances 0.000 description 1
235000013824 polyphenols Nutrition 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
150000004804 polysaccharides Chemical class 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
238000011176 pooling Methods 0.000 description 1
230000008092 positive effect Effects 0.000 description 1
238000004321 preservation Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
238000009516 primary packaging Methods 0.000 description 1
238000003672 processing method Methods 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000012521 purified sample Substances 0.000 description 1
239000002994 raw material Substances 0.000 description 1
238000004064 recycling Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
235000021254 resistant starch Nutrition 0.000 description 1
239000011369 resultant mixture Substances 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
230000033764 rhythmic process Effects 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000005070 sampling Methods 0.000 description 1
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
238000007493 shaping process Methods 0.000 description 1
239000004208 shellac Substances 0.000 description 1
229940113147 shellac Drugs 0.000 description 1
ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
235000013874 shellac Nutrition 0.000 description 1
238000004513 sizing Methods 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
239000011343 solid material Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
229940031000 streptococcus pneumoniae Drugs 0.000 description 1
239000008261 styrofoam Substances 0.000 description 1
239000000758 substrate Substances 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
238000004381 surface treatment Methods 0.000 description 1
230000008961 swelling Effects 0.000 description 1
230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
230000004797 therapeutic response Effects 0.000 description 1
238000002627 tracheal intubation Methods 0.000 description 1
230000014616 translation Effects 0.000 description 1
201000008827 tuberculosis Diseases 0.000 description 1
241001148471 unidentified anaerobic bacterium Species 0.000 description 1
241000712461 unidentified influenza virus Species 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
238000009834 vaporization Methods 0.000 description 1
230000008016 vaporization Effects 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
238000011179 visual inspection Methods 0.000 description 1
238000005303 weighing Methods 0.000 description 1
230000004580 weight loss Effects 0.000 description 1
229920001285 xanthan gum Polymers 0.000 description 1
239000000230 xanthan gum Substances 0.000 description 1
235000010493 xanthan gum Nutrition 0.000 description 1
229940082509 xanthan gum Drugs 0.000 description 1